Literature DB >> 32522835

HMGB1-Neutralizing IgM Antibody Is a Normal Component of Blood Plasma.

Yajun Geng1,2, Gnanasekar Munirathinam1, Sunil Palani1, Joseph E Ross3, Bin Wang4, Aoshuang Chen5, Guoxing Zheng5.   

Abstract

Extracellular high-mobility group box 1 (HMGB1) is a prototypic damage-associated molecular pattern. Although a homeostatic level of extracellular HMGB1 may be beneficial for immune defense, tissue repair, and tissue regeneration, excessive HMGB1 is linked to inflammatory diseases. This prompts an intriguing question: how does a healthy body control the level of extracellular HMGB1? In this study, in the plasma of both healthy humans and healthy mice, we have identified an anti-HMGB1 IgM autoantibody that neutralizes extracellular HMGB1 via binding specifically to a 100% conserved epitope, namely HMW4 (HMGB198-112). In mice, this anti-HMW4 IgM is produced by peritoneal B-1 cells, and concomitant triggering of their BCR and TLR4 by extracellular HMGB1 stimulates the production of anti-HMW4 IgM. The ability of extracellular HMGB1 to induce its own neutralizing Ab suggests a feedback loop limiting the level of this damage-associated molecular pattern in a healthy body.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Year:  2020        PMID: 32522835      PMCID: PMC7416627          DOI: 10.4049/jimmunol.2000014

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

Review 1.  A Hard(y) Look at B-1 Cell Development and Function.

Authors:  Nicole Baumgarth
Journal:  J Immunol       Date:  2017-11-15       Impact factor: 5.422

2.  Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1).

Authors:  Huan Yang; Peter Lundbäck; Lars Ottosson; Helena Erlandsson-Harris; Emilie Venereau; Marco E Bianchi; Yousef Al-Abed; Ulf Andersson; Kevin J Tracey; Daniel J Antoine
Journal:  Mol Med       Date:  2012-03-30       Impact factor: 6.354

3.  Autoantibodies to heat shock proteins 60, 70, and 90 in patients with rheumatoid arthritis.

Authors:  Jagoda Mantej; Kinga Polasik; Ewa Piotrowska; Stefan Tukaj
Journal:  Cell Stress Chaperones       Date:  2018-11-21       Impact factor: 3.667

4.  Inhibitor of NF-kappa B kinases alpha and beta are both essential for high mobility group box 1-mediated chemotaxis [corrected].

Authors:  Marianna Penzo; Raffaella Molteni; Tomomi Suda; Sylvia Samaniego; Angela Raucci; David M Habiel; Frederick Miller; Hui-Ping Jiang; Jun Li; Ruggero Pardi; Roberta Palumbo; Eleonora Olivotto; Richard R Kew; Marco E Bianchi; Kenneth B Marcu
Journal:  J Immunol       Date:  2010-03-15       Impact factor: 5.422

5.  Human anti-60 kD heat shock protein autoantibodies are characterized by basic features of natural autoantibodies.

Authors:  Szabolcs Varbiro; A Biro; J Cervenak; L Cervenak; M Singh; F Banhidy; A Sebestyen; G Füst; Z Prohászka
Journal:  Acta Physiol Hung       Date:  2010-03

6.  High-mobility group box protein 1 neutralization reduces development of diet-induced atherosclerosis in apolipoprotein e-deficient mice.

Authors:  Peter Kanellakis; Alex Agrotis; Tin Soe Kyaw; Christine Koulis; Ingo Ahrens; Shuji Mori; Hideo K Takahashi; Keyue Liu; Karlheinz Peter; Masahiro Nishibori; Alex Bobik
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-18       Impact factor: 8.311

7.  A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin.

Authors:  Valeria V Orlova; Eun Young Choi; Changping Xie; Emmanouil Chavakis; Angelika Bierhaus; Eveliina Ihanus; Christie M Ballantyne; Carl G Gahmberg; Marco E Bianchi; Peter P Nawroth; Triantafyllos Chavakis
Journal:  EMBO J       Date:  2007-02-01       Impact factor: 11.598

Review 8.  High-mobility group box-1 in sterile inflammation.

Authors:  A Tsung; S Tohme; T R Billiar
Journal:  J Intern Med       Date:  2014-11       Impact factor: 8.989

Review 9.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

Review 10.  High Mobility Group Box Protein 1 (HMGB1): The Prototypical Endogenous Danger Molecule.

Authors:  Huan Yang; Haichao Wang; Sangeeta S Chavan; Ulf Andersson
Journal:  Mol Med       Date:  2015-10-27       Impact factor: 6.354

View more
  4 in total

1.  Loss of Id3 (Inhibitor of Differentiation 3) Increases the Number of IgM-Producing B-1b Cells in Ischemic Skeletal Muscle Impairing Blood Flow Recovery During Hindlimb Ischemia.

Authors:  Victoria Osinski; Prasad Srikakulapu; Young Min Haider; Melissa A Marshall; Vijay C Ganta; Brian H Annex; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-11-23       Impact factor: 8.311

Review 2.  Complement System and Alarmin HMGB1 Crosstalk: For Better or Worse.

Authors:  Christine Gaboriaud; Marie Lorvellec; Véronique Rossi; Chantal Dumestre-Pérard; Nicole M Thielens
Journal:  Front Immunol       Date:  2022-04-28       Impact factor: 8.786

3.  Anti-HMGB1 auto-Abs influence fatigue in patients with Crohn's disease.

Authors:  Ingeborg Kvivik; Tore Grimstad; Grete Jonsson; Jan T Kvaløy; Roald Omdal
Journal:  Innate Immun       Date:  2021-05-03       Impact factor: 2.680

Review 4.  High-Mobility Group Box-1 and Its Potential Role in Perioperative Neurocognitive Disorders.

Authors:  Sarah Saxena; Véronique Kruys; Raf De Jongh; Joseph Vamecq; Mervyn Maze
Journal:  Cells       Date:  2021-09-28       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.